Cathie Wood, Ark Investment’s chief executive, has said that the "most underappreciated application of AI" is health care.

BofA raised the firm’s price target on Tempus AI (TEM) to $60 from $54 and keeps a Neutral rating on the shares after the company reported Q4 ...

Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen ...

In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research ...

DeepSeek is a stark reminder about the importance of strategic durability, and not just growth or growth potential, to a ...

Cathie Wood and Ark Invest seized the opportunity on Tuesday to buy the dip on Tempus AI (NASDAQ:TEM) as the stock took a 15% ...

Key Takeaways Tempus AI's fourth-quarter results missed estimates as its costs increased.The medical technology firm's ...

Artificial intelligence tools continue to be a focal point among publicly traded digital health companies looking to improve ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Despite optimistic news from the CEO yesterday afternoon, the company's shares fell overnight and a major investment house ...

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...